Novel Therapeutic Approaches to IBD: Considerations for Optimal Positioning in Clinical Practice



Date & Location
Saturday, January 4, 2020, 12:00 AM - Monday, January 4, 2021, 11:58 PM

Target Audience
Specialties - Gastroenterology, Nurse Practitioners, Nursing, Pharmacy, Physician Assistants, Primary Care

Credits
AMA PRA Category 1 Credits™ (1.25 hours), AMA PRA Category 1 Credits™ Designated (1.25 hours)

Overview
This enduring material was recorded from the live version.  



Objectives
As a result of participating in this activity, participants should be able to:

  1. Describe the current understanding of IBD pathophysiology with respect to inflammatory pathways and potential therapeutic agents
  2. Evaluate the mechanisms of action and available efficacy and safety data surrounding new and emerging therapies for the treatment of IBD
  3. Integrate the latest clinical data into current and future personalized therapeutic strategies for the management of IBD

Accreditation

The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Cincinnati, NACCME and Imedex are accredited by the ACCME to provide continuing medical education for physicians, and have collaborated to design and execute this activity.

For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for this activity.



Additional Information

The opinions expressed during this activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.